Paper · 369586

A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.

O'Connor R and 3 others. Br J Cancer, 1978. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay. Papers, record 369586. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/369586

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.; PubMed
Journal: Br J Cancer; PubMed
Year: 1978; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/369586/; PubMed
DOI: https://doi.org/10.1038/bjc.1978.272; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC2009817/; PubMed
The journal: https://conductscience.org/library/journal-index/0370635; PubMed
Citations, by iCite: 24; iCite
Relative citation ratio, by iCite: 1.12; iCite
Revised in PubMed: 2019-05-15; PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	O'Connor R	R
2	MacFarlane JK	J K
3	Murray D	D
4	Thomson DM	D M

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Breast Neoplasms	Major topic
Immunologic Techniques	Major topic
Leukocyte Adherence Inhibition Test	Major topic
Antigens, Neoplasm
False Negative Reactions
False Positive Reactions
Female
Humans
Neoplasm Staging

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
2	77,673	Isolation of human tumour-specific antigens associated with beta2 microglobulin.	Br J Cancer	1978	https://conductscience.org/library/papers/77673	PubMed
3	73,522	Isolation of breast cancer tumour antigen from serum and urine.	Int J Cancer	1977	https://conductscience.org/library/papers/73522	PubMed
4	402,692	Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia.	Science	1977	https://conductscience.org/library/papers/402692	PubMed
5	369,585	The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.	Br J Cancer	1978	https://conductscience.org/library/papers/369585	PubMed
6	319,891	An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.	Cancer	1977	https://conductscience.org/library/papers/319891	PubMed
7	843,133	The relationship of gross cystic disease of the breast and carcinoma.	Ann Surg	1977	https://conductscience.org/library/papers/843133	PubMed
8	837,365	Macromolecular binding of glucocorticoids in human mammary carcinoma.	Cancer Res	1977	https://conductscience.org/library/papers/837365	PubMed
9	975,111	The isolation and characterization of tumor-specific antigens of rodent and human tumors.	Cancer Res	1976	https://conductscience.org/library/papers/975111	PubMed
10	962,991	Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.	Br J Cancer	1976	https://conductscience.org/library/papers/962991	PubMed
11	59,016	Sensitisation of neuroblastoma patients and related and unrelated contacts to neuroblastoma extracts.	Lancet	1976	https://conductscience.org/library/papers/59016	PubMed

1 to 10 of 18

See all 18 references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMID	Title	Journal	Year	In Papers	Source
7,362,781	Partial purification of organ-specific neoantigens from human colon and breast cancer by affinity chromatography with human tumour-specific gamma-globulin.	Br J Cancer	1980	https://conductscience.org/library/papers/7362781	PubMed
393,293	Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.	Br J Cancer	1979	https://conductscience.org/library/papers/393293	PubMed
228,691	Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.	Br J Cancer	1979	https://conductscience.org/library/papers/228691	PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes
HLA-G	3,135	PubTator's text mining	https://conductscience.org/library/genes/3135

Source NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/369586

GET https://conductscience.org/api/papers/v1/369586/authors

API reference For AI assistants